Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Goldman Sachs Maintains Buy on Morgan Stanley, Lowers Price Target to $93

Goldman Sachs Maintains Buy on Morgan Stanley, Lowers Price Target to $93

Goldman Sachs analyst Richard Ramsden maintains Morgan Stanley (NYSE:MS) with a Buy and lowers the price target from $94 to $93.

byBenzinga Newsdesk

October 4, 2022

1 minute read

Goldman Sachs analyst Richard Ramsden maintains Morgan Stanley (NYSE:MS) with a Buy and lowers the price target from $94 to $93.

News

Logitech Taps iFixit to Advance Circularity Goals

By Benzinga Newsdesk

May 17, 3:18 AM

Logitech International (SIX: LOGN) (NASDAQ:LOGI) announced today that it is partnering with iFixit, a global repair community that sells replacement parts and provides toolkits and repair guides for

LOGI

On Holding’s Strong Brand Momentum Remains Unchanged, Analyst Says

By Shivani Kumaresan

March 16, 1:35 PM

Telsey Advisory Group analyst Cristina Fernández reiterated an Outperform rating on the shares of On Holding AG (NYSE:ONON) with a price target…

ONON

Now Entering The Co-Pilot Era: Generative AI Is ‘A Gold Rush,’ Google Veteran Says

By Renato Capelj

April 4, 11:29 AM

Generative artificial intelligence, or GenAI, is revolutionizing storytelling, according to Bilawal Sidhu.

ADSK

Why Are Plus Therapeutics Shares Gaining Today?

By Vandana Singh

September 22, 8:35 AM

Plus Therapeutics Inc (NASDAQ:PSTV) has finalized and signed a grant contract with the Cancer Prevention & Research Institute of Texas (CPRIT)…

PSTV

Goldman Sachs Maintains Buy on Morgan Stanley, Lowers Price Target to $93

Related Posts

Logitech Taps iFixit to Advance Circularity Goals

On Holding’s Strong Brand Momentum Remains Unchanged, Analyst Says

Now Entering The Co-Pilot Era: Generative AI Is ‘A Gold Rush,’ Google Veteran Says

Why Are Plus Therapeutics Shares Gaining Today?